http://www.bing.com:80/search?q=Int+Data+Type+PythonSearch resultshttp://www.bing.com:80/s/a/rsslogo.gifhttp://www.bing.com:80/search?q=Int+Data+Type+PythonCopyright © 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.https://www.hims.com/Men’s healthcare, built for real life. Get access to expert-backed weight loss care, ED treatment options, in-depth lab testing, testosterone support, and more—all 100% online.Mon, 17 Aug 2026 03:46:00 GMThttps://www.hims.com/g/i/wmHims ... HimsFri, 14 Aug 2026 12:18:00 GMThttps://support.hims.com/hc/en-us/categories/360002039332-my-accountPayment Information How do I update my payment information? App Access the Hims or Hers app on your mobile device. Log into your account. How do I log into my account? Locate the account icon in the top right corner. Scroll down until you see "Payment Method". You will see a brief overview of the current card information. Tap to make changes.Sun, 16 Aug 2026 17:02:00 GMThttps://support.hims.com/hc/en-us/articles/38844586841115-Compounded-Semaglutide-InjectablePatient Drug Information Compounded Semaglutide Injectable Weight loss treatment BPG-WL-SEMAGLUTIDE-PIB-OHAZ-05 About your prescription medication: Written information about this medication has been provided for you. Please read this information before you take this medication. If you have questions concerning this medication, a pharmacist is available during normal business hours to answer ...Fri, 14 Aug 2026 07:24:00 GMThttps://investors.hims.com/news/news-details/2026/Hims--Hers-Expands-GLP-1-Offering-in-Canada-with-Generic-Semaglutide/default.aspxSAN FRANCISCO-- (BUSINESS WIRE)-- Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the availability of generic semaglutide through its platform in Canada. This is Hims & Hers’ first international generic GLP-1 offering, demonstrating the company’s ability to meet the unique needs of each global market it serves while continuing its ...Mon, 17 Aug 2026 00:11:00 GMThttps://news.hims.com/newsroom/2026-the-year-of-the-consumer-in-healthcare2026 is the year of the individual in healthcare, and we’ve built Hims & Hers to be the leader in empowering every kind of customer on their health and wellness journey.Wed, 12 Aug 2026 20:20:00 GMThttps://investors.hims.com/news/news-details/2026/Hims--Hers-Health-Inc--Reports-First-Quarter-2026-Financial-Results/default.aspxSAN FRANCISCO-- (BUSINESS WIRE)-- Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading health and wellness platform, today announced financial results for the first quarter ended March 31, 2026. Moving forward, the Company plans to transition to an annual rather than quarterly shareholder letter and will continue to provide regular updates through a ...Mon, 17 Aug 2026 12:36:00 GMThttps://link.app.hims.com/Get everything you need to take better care - all in one place. With Hims, best-in-class treatments for hair, skin, sex, and mental health are just the beginning. Now, you can experience specially-curated health and wellness support designed to complementMon, 17 Aug 2026 06:59:00 GMThttps://news.hims.com/Hims & Hers expands capabilities to ultimately include affordable at-home testing for subscribers February 19, 2025 Company NewsMon, 17 Aug 2026 10:56:00 GMThttps://app.hims.com/Best-in-class treatment, and beyond. Explore Programs curated to your treatment, contact Care for support anytime from anywhere, and Shop the entire collection of products—all in the app.Sun, 16 Aug 2026 21:20:00 GMT